Momelotinib for the treatment of myelofibrosis with anemia.
Sign Up to like & getrecommendations! Published in 2022 at "Future oncology"
DOI: 10.2217/fon-2022-0276
Abstract: Myelofibrosis is a myeloproliferative neoplasm characterized by splenomegaly, debilitating constitutional symptoms and bone marrow failure. Disease-related anemia is common and associated with an inferior quality of life and survival. Unfortunately, few therapies exist to improve hemoglobin… read more here.
Keywords: treatment myelofibrosis; myelofibrosis anemia; myelofibrosis; momelotinib ... See more keywords